Vivos (RDGL) Change in Receivables (2010 - 2025)
Vivos (RDGL) reported Change in Receivables of $17632.0 for Q4 2025, up 231.06% on a YoY basis from $5326.0 in Q4 2024, and up 305.72% sequentially from -$8571.0 in Q3 2025.
Vivos (RDGL) Change in Receivables (2010 - 2025) Analysis & Trends
Vivos (RDGL) has 8 years of Change in Receivables data on file, last reported at $17632.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Receivables rose 231.06% year-over-year to $17632.0; the trailing twelve-month figure through Dec 2025 stood at $12005.0 (up 260.94% YoY), and the FY2025 full-year result was $12005.0, up 260.94% from the prior year.
- Change in Receivables climbed to $17632.0 in Q4 2025, from -$8571.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $17632.0 in Q4 2025 to a low of -$11000.0 in Q1 2023.
- A 4-year average of $1395.7 and a median of $2000.0 in 2023 frame the typical range for Change in Receivables.
- Peak annual rise in Change in Receivables reached 632.6% in 2024, while the deepest fall reached 525.0% in 2024.
- Tracing RDGL's Change in Receivables over 4 years: stood at -$2000.0 in 2022, then jumped by 50.0% to -$1000.0 in 2023, then jumped by 632.6% to $5326.0 in 2024, then jumped by 231.06% to $17632.0 in 2025.
- Business Quant data shows RDGL's Change in Receivables at $17632.0 in Q4 2025, -$8571.0 in Q3 2025, and $4566.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.86 Bn | 175.56 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 108.31 Bn | 99.09 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 48.25 Bn | 44.58 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | -124.60 Mn |
| 7 | GE HealthCare Technologies | 28.05 Bn | 25.76 Bn | 1.98 Bn | -141.00 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | - |
| 10 | Vivos | 27.62 Mn | 26.06 Mn | -3,105.00 | 17,632.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17,632.00 |
| Dec 31, 2025 | 17,632.00 |
| Sep 30, 2025 | -8,571.00 |
| Sep 30, 2025 | -8,571.00 |
| Jun 30, 2025 | 4,566.00 |
| Jun 30, 2025 | 4,566.00 |
| Mar 31, 2025 | -1,622.00 |
| Mar 31, 2025 | -1,622.00 |
| Dec 31, 2024 | 5,326.00 |
| Dec 31, 2024 | 5,326.00 |
| Sep 30, 2024 | -8,500.00 |
| Sep 30, 2024 | -8,500.00 |
| Jun 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 4,500.00 |
| Mar 31, 2024 | 4,500.00 |
| Dec 31, 2023 | -1,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Sep 30, 2023 | 2,000.00 |